GenesisCare has expanded its UK oncology network with the acquisition of two Spire Healthcare cancer centres.
The cancer treatment specialist has signed a deal to acquire the Spire Oncology Centre, South West in Bristol and the Spire Specialist Care Centre in Chelmsford, Essex.
GenesisCare has also entered into a partnership with Spire Bristol Hospital to jointly deliver services.
The ‘GenesisCare Bristol’ service will offer comprehensive cancer care to private patients, with Spire Healthcare continuing to provide complementary oncology services in the area.
The two sites will become part of GenesisCare from November 2019, and will offer radiotherapy treatments, as well as chemotherapy treatments, diagnostic imaging and personalised wellbeing services.
‘Through our partnership with Spire Healthcare in Bristol, we will offer patients a seamless journey through their cancer treatment, removing some of the common difficulties of switching between multiple providers and various locations to receive care,’ said James McArthur, UK general manager at GenesisCare. ‘This exciting new model harnesses innovation and a multidisciplinary team approach to ensure every patient receives the best treatment and aftercare, from initial diagnosis and treatment planning through to chemotherapy, radiotherapy and surgery.’
Justin Ash, chief executive officer of Spire Healthcare, said: ‘We anticipate that the partnership with GenesisCare will form the template for future partnerships and we have signed a Memorandum of Understanding to work towards rolling out similar care pathways in future locations.’
©2024 All rights reserved LaingBuisson 
